Apocryphal FADS2 activity promotes fatty acid diversification in cancer

Reuben S.E. Young; Andrew P. Bowman; Elizabeth D. Williams; Kaylyn D. Tousignant; Charles L. Bidgood; Venkateswara R. Narreddula; Rajesh Gupta; David L. Marshall; Berwyck L.J. Poad; Colleen C. Nelson; Shane R. Ellis; Ron M.A. Heeren; Martin C. Sadowski; Stephen J. Blanksby

Cell Reports (Feb 2021)

Apocryphal FADS2 activity promotes fatty acid diversification in cancer

Reuben S.E. Young,
Andrew P. Bowman,
Elizabeth D. Williams,
Kaylyn D. Tousignant,
Charles L. Bidgood,
Venkateswara R. Narreddula,
Rajesh Gupta,
David L. Marshall,
Berwyck L.J. Poad,
Colleen C. Nelson,
Shane R. Ellis,
Ron M.A. Heeren,
Martin C. Sadowski,
Stephen J. Blanksby

Affiliations

Reuben S.E. Young: School of Chemistry and Physics, Queensland University of Technology, Brisbane, QLD 4000, Australia
Andrew P. Bowman: M4I, The Maastricht MultiModal Molecular Imaging Institute, Division of Imaging Mass Spectrometry, Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, the Netherlands
Elizabeth D. Williams: Australian Prostate Cancer Research Centre—Queensland, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology (QUT), Princess Alexandra Hospital, Translational Research Institute, Brisbane, QLD 4000, Australia
Kaylyn D. Tousignant: Australian Prostate Cancer Research Centre—Queensland, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology (QUT), Princess Alexandra Hospital, Translational Research Institute, Brisbane, QLD 4000, Australia
Charles L. Bidgood: Australian Prostate Cancer Research Centre—Queensland, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology (QUT), Princess Alexandra Hospital, Translational Research Institute, Brisbane, QLD 4000, Australia
Venkateswara R. Narreddula: School of Chemistry and Physics, Queensland University of Technology, Brisbane, QLD 4000, Australia
Rajesh Gupta: Central Analytical Research Facility, Institute for Future Environments, Queensland University of Technology, 2 George St., Brisbane, QLD 4000, Australia
David L. Marshall: Central Analytical Research Facility, Institute for Future Environments, Queensland University of Technology, 2 George St., Brisbane, QLD 4000, Australia
Berwyck L.J. Poad: School of Chemistry and Physics, Queensland University of Technology, Brisbane, QLD 4000, Australia; Central Analytical Research Facility, Institute for Future Environments, Queensland University of Technology, 2 George St., Brisbane, QLD 4000, Australia
Colleen C. Nelson: Australian Prostate Cancer Research Centre—Queensland, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology (QUT), Princess Alexandra Hospital, Translational Research Institute, Brisbane, QLD 4000, Australia
Shane R. Ellis: M4I, The Maastricht MultiModal Molecular Imaging Institute, Division of Imaging Mass Spectrometry, Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, the Netherlands; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia
Ron M.A. Heeren: M4I, The Maastricht MultiModal Molecular Imaging Institute, Division of Imaging Mass Spectrometry, Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, the Netherlands
Martin C. Sadowski: Australian Prostate Cancer Research Centre—Queensland, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology (QUT), Princess Alexandra Hospital, Translational Research Institute, Brisbane, QLD 4000, Australia; Institute of Pathology, University of Bern, Murtenstrasse 31, 3008 Bern, Switzerland; Corresponding author
Stephen J. Blanksby: School of Chemistry and Physics, Queensland University of Technology, Brisbane, QLD 4000, Australia; Central Analytical Research Facility, Institute for Future Environments, Queensland University of Technology, 2 George St., Brisbane, QLD 4000, Australia; Corresponding author

Journal volume & issue: Vol. 34, no. 6
p. 108738

Abstract

Read online

Summary: Canonical fatty acid metabolism describes specific enzyme-substrate interactions that result in products with well-defined chain lengths, degree(s), and positions of unsaturation. Deep profiling of lipids across a range of prostate cancer cell lines reveals a variety of fatty acids with unusual site(s) of unsaturation that are not described by canonical pathways. The structure and abundance of these unusual lipids correlate with changes in desaturase expression and are strong indicators of cellular phenotype. Gene silencing and stable isotope tracing demonstrate that direct Δ6 and Δ8 desaturation of 14:0 (myristic), 16:0 (palmitic), and 18:0 (stearic) acids by FADS2 generate new families of unsaturated fatty acids (including n-8, n-10, and n-12) that have rarely—if ever—been reported in human-derived cells. Isomer-resolved lipidomics reveals the selective incorporation of these unusual fatty acids into complex structural lipids and identifies their presence in cancer tissues, indicating functional roles in membrane structure and signaling.

Published in Cell Reports

ISSN: 2211-1247 (Online)
Publisher: Elsevier
Country of publisher: Netherlands
LCC subjects: Science: Biology (General)
Website: http://www.cell.com/cell-reports/home

About the journal

Abstract

Keywords